B2M and colorectal carcinoma: Although a previous study has shown that B2M was the most highly downregulated gene in CRC compared to adjacent normal tissue (Bianchini et al, 2006), this is the first study to show a relationship between B2M mRNA levels and a clinical parameter related to outcome of CRC patients.